glp-1 obesity drug news today october 23 2025 1 in 10 Americans Has Used Drugs For Weight Loss, Survey Says MedNews Alarming rise in weight loss
Description
The study period on medication or placebo following the lifestyle intervention is 72 weeks (84)
Its naturally present in a healthy gut, but its levels decline with poor diet, stress, antibiotics, aging, and other modern lifestyle factors
Yabe D, Nakamura J, Kaneto H, Deenadayalan S, Navarria A, Gislum M, et al
Results GLP-1 receptor agonists versus DPP-4 inhibitors The cohort included 36 082 and 234 028 new users of GLP-1 receptor agonists and DPP-4 inhibitors, respectively (fig 1)
Halloum W, Dughem Y Al, Beier D, et al
There are at least two ways to read this
